MOA of barbituates
bind to barbituate binding site on GABA-A receptors
at high doses can act at GABA site
CNS effects
reduce anxiety and hypnotic property
hard to separate, unlike benzodiazepines
Pharmacokinetics of barbituates
strongly induce P450
Barbituate intoxication
narrow therapeutic index
Dependence on barbituates
physical dependence can be a serious problem. Tolerance develops to sedative-hypnotic effects, but not toxic effects